What CAS MEDICAL SYSTEMS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Holding, Inc. | 10% owner | Apr 18 | Other Transaction · J | +40,049,789 | — | — | 40,049,789 |
| Patton Thomas M | President and CEO | Apr 18 | Disposition to Issuer · D | −150,000 | — | — | 0 |
| Patton Thomas M | President and CEO | Apr 18 | Disposition to Issuer · D | −930,889 | $2.45 | −$2.28M | 150,000 |
| Weisshaar Kenneth R | Director | Apr 18 | Disposition to Issuer · D | −70,303 | $2.45 | −$172K | 0 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Disposition to Issuer · D | −119,872 | $2.45 | −$294K | 0 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Disposition to Issuer · D | −43,944 | $2.45 | −$108K | 0 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Disposition to Issuer · D | −12,300,186 | $2.45 | −$30.1M | 0 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +40,772 | $2.39 | +$97.4K | 119,872 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +3,906,315 | $2.39 | +$9.33M | 12,300,186 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +71,075 | $2.39 | +$170K | 79,100 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +24,125 | $2.39 | +$57.6K | 30,063 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +6,802,834 | $2.39 | +$16.3M | 8,393,871 |
| Tune Kathleen A | Director | Apr 18 | Disposition to Issuer · D | −63,454 | $2.45 | −$155K | 0 |
| Benni Paul | Chief Scientific Officer | Apr 18 | Disposition to Issuer · D | −177,379 | $2.45 | −$435K | 0 |
| Gamelin John | Vice President, R&D | Apr 18 | Disposition to Issuer · D | −186,078 | $2.45 | −$456K | 0 |
| Thomas, McNerney & Partners Ii L.p. | 10% owner | Apr 18 | Derivative Conversion · C | +13,881 | $2.39 | +$33.2K | 43,944 |
| Milinazzo Alan | Director | Apr 18 | Disposition to Issuer · D | −42,500 | $2.45 | −$104K | 0 |
| Rainey Gregory P | Director | Apr 18 | Disposition to Issuer · D | −70,431 | $2.45 | −$173K | 0 |
| Thomas James E | Director | Apr 18 | Disposition to Issuer · D | −63,454 | $2.45 | −$155K | 0 |
| Molloy Paul A | Director | Apr 18 | Disposition to Issuer · D | −42,500 | $2.45 | −$104K | 0 |
Loading...